Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

By News Health
14 hours Ago

(MedPage Today) — SAN FRANCISCO — A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre…

Source link : https://www.medpagetoday.com/meetingcoverage/croi/114653

Author :

Publish date : 2025-03-14 14:37:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Medicare Pay Cut Stands as Congress Passes Budget Bill

Probiotics Cut Fever Duration in Kids With Upper Respiratory Infections

Therapy Dogs Cut Anxiety for Children in the ED

Studies Hint at Potential Negative Effects of GLP-1 Drugs in Orthopedic Patients

Proteinuria Linked to Sudden Cardiac Arrest in Young Adults

Paradoxical PSA Association With Mortality After Radical Prostatectomy